Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cloning, Optimization of Periplasmic Expression and Purification of Recombinant Granulocyte Macrophage-Stimulating Factor in Escherichia Coli Bl21 (De3) Publisher



Taherian E1 ; Mohammadi E1 ; Jahaniannajafabadi A1 ; Moazen F1 ; Akbari V1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pharmaceutical Biotechnology, Isfahan Pharmaceutical Research Center, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Advanced Biomedical Research Published:2019


Abstract

Background: Molgramostim, a nonglycosylated version of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF), can be produced in a high level by Escherichia coli. However, overexpression of GM-CSF in bacterial cells usually leads to formation of inclusion bodies and insoluble protein aggregates which are not biologically active. The aim of the present study was to improve the expression of soluble and biologically active GM-CSF in periplasmic space of E. coli BL21 (DE3). Materials and Methods: The codon-optimized GM-CSF gene was subcloned into pET-22b expression vector, in frame with the pelB secretion signal peptide for periplasmic secretion. Cultivation conditions including as isopropyl β-D-1-thiogalactopyranoside (IPTG) concentration, incubation temperature, and presence of sucrose were optimized to improve periplasmic expression of GM-CSF. The expressed protein was purified using Ni-NTA affinity column. Biological activity of GM-CSF on HL-60 cells was evaluated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Results: The amount of soluble protein for periplasmic expression was more when compared with one of the cytoplasmic expressions. The optimum condition for periplasmic expression of GM-CSF was expression at 23°C, using 1 mM IPTG as inducer and in the presence of 0.4 M sucrose. The biological activity of purified GM-CSF on HL-60 cell line was assessed by MTT assay, and the specific activity of produced GM-CSF was determined as 1.2 × 104 IU/μg. Conclusion: The present work suggests that periplasmic expression and optimization of cultivation conditions could improve soluble expression of recombinant proteins by E. coli. © 2019 Advanced Biomedical Research | Published by Wolters Kluwer - Medknow.
Related Docs
View other Related Docs
1. Evaluation of Soluble Expression of Recombinant Granulocyte Macrophage Stimulating Factor (Rgm-Csf) by Three Different E. Coli Strains, Research in Pharmaceutical Sciences (2020)
2. High-Yield Production of Granulocyte-Macrophage Colony-Stimulating Factor in E. Coli Bl21 (De3) by an Auto-Induction Strategy, Iranian Journal of Pharmaceutical Research (2019)
3. Improvement of Soluble Expression of Gm-Csf in the Cytoplasm of Escherichia Coli Using Chemical and Molecular Chaperones, Protein Expression and Purification (2019)
4. Optimization of Buffer Additives for Efficient Recovery of Hgm-Csf From Inclusion Bodies Using Response Surface Methodology, Iranian Journal of Pharmaceutical Research (2020)
5. Expression and Purification of Biologically Active Recombinant Rabbit Monocyte Chemoattractant Protein1 in Escherichia Coli, FEMS Microbiology Letters (2018)
6. The Increase in Protein and Plasmid Yields of E. Coli With Optimized Concentration of Ampicillin As Selection Marker, Iranian Journal of Biotechnology (2017)
7. Optimization of the Expression of Reteplase in Escherichia Coli Top10 Using Arabinose Promoter, Jundishapur Journal of Natural Pharmaceutical Products (2015)
8. Co-Expression of Chaperones for Improvement of Soluble Expression and Purification of an Anti-Her2 Scfv in Escherichia Coli, Advanced Biomedical Research (2022)
Experts (# of related papers)
View all Related Experts
Vajihe Akbari (9)
Ali Jahanian Najafabadi (8)
Other Related Docs
9. Twin Arginine Translocation System in Secretory Expression of Recombinant Human Growth Hormone, Research in Pharmaceutical Sciences (2016)
10. Efficient Process Development of Recombinant Human Granulocyte Colony-Stimulating Factor (Rh-Gcsf) Production in Escherichia Coli, Iranian Biomedical Journal (2015)
11. Improvement of Solubility and Refolding of an Anti-Human Epidermal Growth Factor Receptor 2 Single-Chain Antibody Fragment Inclusion Bodies, Research in Pharmaceutical Sciences (2018)
12. Effect of Tat-Signaling Fusion System Along With Co-Expression of Groel/Es Chaperones on Secretory Expression of Somatropin, Biotechnologia (2020)
13. Reteplase: Structure, Function, and Production, Advanced Biomedical Research (2019)
14. Integrated Bioprocessing and Genetic Strategies to Enhance Soluble Expression of Anti-Her2 Immunotoxin in E. Coli, AMB Express (2024)
15. Comparison of the Cytoplasmic and Periplasmic Production of Reteplase in Escherichia Coli, Preparative Biochemistry and Biotechnology (2013)
16. Improvement of Soluble Production of Reteplase in Escherichia Coli by Optimization of Chemical Chaperones in Lysis Buffer, Advanced Biomedical Research (2019)
17. Optimization of Fermentation Conditions for Reteplase Expression by Escherichia Coli Using Response Surface Methodology, Avicenna Journal of Medical Biotechnology (2019)
18. Expression and One Step Intein-Mediated Purification of Biologically Active Human G-Csf in Escherichia Coli, Molecular Biology Reports (2020)
19. Expression of Recombinant G-Csf Receptor Domains and Their Inhibitory Role on G-Csf Function, Research in Pharmaceutical Sciences (2020)
20. Recombinant Production, Purification and Characterization of Vessel Dilator in E. Coli, Protein Expression and Purification (2017)
21. Improvement of Solubility and Yield of Recombinant Protein Expression in E. Coli Using a Two-Step System, Research in Pharmaceutical Sciences (2019)
22. Recombinant Protein Expression in Escherichia Coli (E.Coli): What We Need to Know, Current Pharmaceutical Design (2018)